Anushka Patel's Publications

About Anushka Patel's Publications

Chief Executive Officer, The George Institute for Global Health
  • Scientia Professor, Faculty of Medicine, UNSW Sydney
  • Cardiologist (Hon), Royal Prince Alfred Hospital
  • MBBS,
  • SM,
  • PhD,
  • FRACP ,
  • FAHMS,
  • GAICD

  • Cardiovascular disease risk management for Aboriginal and Torres Strait Islander peoples in primary health care settings: findings from the Kanyini Audit

    Medical Journal of Australia Date published:

  • Gaps in cardiovascular disease risk management in Australian general practice

    Medical Journal of Australia Date published:

  • Smoking, diabetes and cardiovascular diseases in men in the Asia Pacific region

    Journal of Diabetes Date published:

  • Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

    Diabetologia Date published:

  • Intensive glucose control and macrovascular outcomes in type 2 diabetes

    Diabetologia Date published:

  • Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes

    Diabetes Care Date published:

  • Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes

    Journal of the American Society of Nephrology Date published:

  • Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial

    Diabetologia Date published:

  • Trials of cardiovascular risk factor management in type 2 diabetes

    Current Opinion in Cardiology Date published:

  • JOINT EFFECTS OF BLOOD PRESSURE LOWERING AND GLUCOSE CONTROL IN THE ADVANCE TRIAL

    Date published:

  • INDEPENDENT IMPACT OF ALBUMINURIA AND KIDNEY FUNCTION ON CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES: RESULTS FROM THE ADVANCE TRIAL

    Date published:

  • THE FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE HAS A GREATER EFFECT ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND ALBUMINURIA

    Date published:

  • THE EFFECTS OF A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ACCORDING TO BASELINE CARDIOVASCULAR RISK IN THE ADVANCE TRIAL

    Date published:

  • How to Treat - Cardiovascular Risk Assessment

    Australian Doctor Date published:

  • Nuevas perspectivas en el tratamiento del paciente diabético. Estudio ADVANCE

    Hipertensión y Riesgo Vascular Date published:

  • Management of Cardiovascular Risk Factors in Australian General Practice of Those at Highest Risk

    Australasian Epidemiologist Date published: